147 related articles for article (PubMed ID: 37001607)
1. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
Zhao R; Sekar P; Bennis SL; Kulasingam S
Prev Med; 2023 May; 170():107494. PubMed ID: 37001607
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
[TBL] [Abstract][Full Text] [Related]
3. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
Chachage M; Parikh AP; Mahenge A; Bahemana E; Mnkai J; Mbuya W; Mcharo R; Maganga L; Mwamwaja J; Gervas R; Kibuuka H; Maswai J; Singoei V; Iroezindu M; Fasina A; Esber A; Dear N; Imbach M; Crowell TA; Hern J; Song X; Hoelscher M; Polyak CS; Ake JA; Geldmacher C;
AIDS; 2023 Mar; 37(4):625-635. PubMed ID: 36398743
[TBL] [Abstract][Full Text] [Related]
4. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
[TBL] [Abstract][Full Text] [Related]
5. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus prevalence in pregnant women living with human immunodeficiency virus infection: a scoping review of the literature.
Metz CK; Skof AS; Henrich W; Sehouli J; Kaufmann AM; Rohr I
J Perinat Med; 2024 Jan; 52(1):1-13. PubMed ID: 37540166
[TBL] [Abstract][Full Text] [Related]
7. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
8. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
Wagner A; Skof AS; Sehouli J; Richter R; Henrich W; von Weizsäcker K; Siedentopf JP; Chekerov R; Kaufmann AM; Rohr I
Int J Gynecol Cancer; 2022 Jun; 32(6):716-723. PubMed ID: 35354606
[TBL] [Abstract][Full Text] [Related]
9. HPV infection and pre-neoplastic cervical lesions among 321 HIV+ women in Florence, Italy, 2006-2016: prevalence and associated factors.
Fusco FM; Vichi F; Bisanzi S; Sani C; Degli Esposti A; Blè C; Rossi R; Pompeo G; Carozzi F; Blanc P
New Microbiol; 2018 Oct; 41(4):268-273. PubMed ID: 30252922
[TBL] [Abstract][Full Text] [Related]
10. Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse.
Feng RM; Hu SY; Zhao FH; Zhang R; Zhang X; Wallach AI; Qiao YL
J Gynecol Oncol; 2017 Sep; 28(5):e47. PubMed ID: 28657217
[TBL] [Abstract][Full Text] [Related]
11. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
[TBL] [Abstract][Full Text] [Related]
12. Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.
Adedimeji A; Ajeh R; Dzudie A; Kendowo E; Fuhngwa N; Nsame D; Simo-Wambo AG; Orock E; Hebert TM; Pierz AJ; Murokora D; Anastos K; Castle PE
J Clin Virol; 2020 Jul; 128():104445. PubMed ID: 32470891
[TBL] [Abstract][Full Text] [Related]
13. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
[TBL] [Abstract][Full Text] [Related]
14. High-risk HPV positivity is a long-term risk factor for recurrence after cervical excision procedure in women living with HIV.
Agarossi A; Delli Carpini G; Sopracordevole F; Serri M; Giannella L; Gardella B; Maestri M; Del Fabro A; Sansone M; Fallani MG; Pieralli A; Fasolo MM; Mazzali C; Ciavattini A
Int J Gynaecol Obstet; 2021 Dec; 155(3):442-449. PubMed ID: 33721323
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
[TBL] [Abstract][Full Text] [Related]
16. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.
Musa J; Taiwo B; Achenbach C; Olugbenga S; Berzins B; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
Arch Gynecol Obstet; 2013 Dec; 288(6):1365-70. PubMed ID: 23700253
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology.
Grover S; Seckar T; Gao L; Bhatia R; Lin X; Zetola N; Ramogola-Masire D; Robertson E
Tumour Virus Res; 2023 Jun; 15():200262. PubMed ID: 37209888
[TBL] [Abstract][Full Text] [Related]
18. The vaginal microbiota of women living with HIV on suppressive antiretroviral therapy and its relation to high-risk human papillomavirus infection.
Chávez-Torres M; Gómez-Palacio-Schjetnan M; Reyes-Terán G; Briceño O; Ávila-Ríos S; Romero-Mora KA; Pinto-Cardoso S
BMC Microbiol; 2023 Jan; 23(1):21. PubMed ID: 36658503
[TBL] [Abstract][Full Text] [Related]
19. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.
Jensen KE; Schmiedel S; Frederiksen K; Norrild B; Iftner T; Kjær SK
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1949-55. PubMed ID: 23019238
[TBL] [Abstract][Full Text] [Related]
20. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
